Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Goodwill: 2010-2024

Historic Goodwill for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $7.1 million.

  • Anika Therapeutics' Goodwill rose 5.16% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 5.16%. This contributed to the annual value of $7.1 million for FY2024, which is 5.89% down from last year.
  • According to the latest figures from FY2024, Anika Therapeutics' Goodwill is $7.1 million, which was down 5.89% from $7.6 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Goodwill registered a high of $8.4 million during FY2020, and its lowest value of $7.1 million during FY2024.
  • Over the past 3 years, Anika Therapeutics' median Goodwill value was $7.3 million (recorded in 2022), while the average stood at $7.3 million.
  • As far as peak fluctuations go, Anika Therapeutics' Goodwill climbed by 9.34% in 2020, and later dropped by 7.51% in 2021.
  • Yearly analysis of 5 years shows Anika Therapeutics' Goodwill stood at $8.4 million in 2020, then dropped by 7.51% to $7.8 million in 2021, then decreased by 5.68% to $7.3 million in 2022, then increased by 3.16% to $7.6 million in 2023, then decreased by 5.89% to $7.1 million in 2024.